SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Frederick Cook Synthetic CCD

PatientFrederick Cook
Date of birth1961-06-10
IdentifiersMRN HR-EX006-SYN; SSN (made up) 000-06-4471
Document date2026-11-01
AuthorHarriet Okafor-Brandt, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

New patient visit to establish care after release from prison: history, medication reconciliation, blood pressure, a right carotid bruit, re-entry screening for hepatitis C, tuberculosis and HIV, mood and social needs, and a vascular neurology referral. Concerns: He worries that people will recognize him and that his conviction and the disputes over his claims will follow him to every landlord and employer; He wants to stay well enough to finish his memoirs, and he does not want to depend on anyone. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Hydrochlorothiazide 25 mg tablet, one tablet by mouth each morningonce daily in the morningOral route2026-07-21 to 2026-09-29completedS
Amlodipine 5 mg tablet, one tablet by mouth dailyonce dailyOral route2026-07-21activeS
Atorvastatin 40 mg tablet, one tablet by mouth dailyonce dailyOral route2026-07-21activeS
Aspirin 81 mg delayed-release tablet, one tablet by mouth dailyonce dailyOral route2026-07-21activeS
Losartan 50 mg tablet, one tablet by mouth dailyonce dailyOral route2026-09-29activeS
Colchicine 0.6 mg tablet: two tablets at once, one more an hour later, then one tablet twice a day until the flare settles, for up to a week1.2 mg, then 0.6 mg an hour later, then 0.6 mg twice daily for up to a weekOral route2026-09-08 to 2026-09-13completedS

Procedures

ProcedureDatesStatusEvidence
Resting twelve-lead electrocardiogram: sinus rhythm, 72 per minute, normal axis and intervals, no left ventricular hypertrophy by voltage, no Q waves2026-07-07 to 2026-07-07completedS
Duplex ultrasound of both carotid arteries: right internal carotid peak systolic velocity 165 cm/s, end-diastolic velocity 38 cm/s, internal-to-common carotid ratio 2.6, heterogeneous plaque, consistent with 50 to 69 percent stenosis; left internal carotid peak systolic velocity 96 cm/s with less than 50 percent plaque; both vertebral arteries with antegrade flow2026-07-21 to 2026-07-21completedS
Advance care planning conversation, about 20 minutes2026-08-04 to 2026-08-04completedS
Transthoracic echocardiogram: normal left ventricular size and wall thickness, no left ventricular hypertrophy, ejection fraction about 60 percent, normal diastolic function for age, mild aortic valve sclerosis without stenosis2026-08-18 to 2026-08-18completedS

Immunizations

DateVaccineStatusEvidence
2026-08-04Pneumococcal conjugate vaccine (PCV20)completedS
2026-08-04Recombinant zoster vaccine, dose 1 of 2completedS
2026-08-04Tdap vaccinecompletedS
2026-08-04Hepatitis B vaccine, CpG-adjuvanted (two-dose series), dose 1 of 2completedS
2026-09-29Hepatitis B vaccine, CpG-adjuvanted (two-dose series), dose 2 of 2completedS
2026-10-27Influenza vaccine, high-dose, trivalentcompletedS
2026-10-27Recombinant zoster vaccine, dose 2 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1891 to 1899Physician on Arctic and Antarctic expeditions in his late twenties and early thirties, including a winter in the Antarctic pack ice in which he treated the crew's scurvy; no illness of his own is recorded in the cited sourcesD (CLM-0003, CLM-0004)

Family History

RelativeConditionAge at deathEvidence
fatherA physician; died of pneumonia when the patient was fiveD (CLM-0002)

Health Concerns

ConcernStatusEvidence
He worries that people will recognize him and that his conviction and the disputes over his claims will follow him to every landlord and employeractiveS
He wants to stay well enough to finish his memoirs, and he does not want to depend on anyoneactiveS

Assessment

Most recent measures: Sodium [Moles/volume] in Serum or Plasma 139 on 2026-10-27; Potassium [Moles/volume] in Serum or Plasma 4.5 on 2026-10-27; Creatinine [Mass/volume] in Serum or Plasma 1.06 on 2026-10-27; Glucose [Mass/volume] in Serum or Plasma 94 on 2026-07-07; Hemoglobin A1c/Hemoglobin.total in Blood 5.5 on 2026-07-07; Hemoglobin [Mass/volume] in Blood 14.1 on 2026-07-07; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 26 on 2026-09-29; Thyrotropin [Units/volume] in Serum or Plasma 2.1 on 2026-07-07; Albumin/Creatinine [Mass Ratio] in Urine 18 on 2026-07-07; Cholesterol [Mass/volume] in Serum or Plasma 142 on 2026-09-29; Cholesterol in HDL [Mass/volume] in Serum or Plasma 48 on 2026-09-29; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 68 on 2026-09-29; Triglyceride [Mass/volume] in Serum or Plasma 130 on 2026-09-29; Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay 0.08 on 2026-07-07; Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] corrected for background in Blood 0.02 on 2026-07-07; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 78 on 2026-10-27; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 2026-10-27; Urate [Mass/volume] in Serum or Plasma 8.4 on 2026-09-29; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 on 2026-08-04 [S]

Strengths and supports: engagement in care [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Elevated blood pressure at the first visit, 166/94 mmHg (average of two seated readings), without a previous diagnosis of hypertension; no symptoms; out-of-office confirmation with a week of home readings requestedresolvedconfirmed R03.0S — Synthetic presenting finding at re-entry; superseded by the diagnosis at the second visit.
Essential hypertension, stage 2, confirmed by home readings averaging 154/90 mmHg; no left ventricular hypertrophy on ECG; urine albumin normalactiveconfirmed I10S — Synthetic modern diagnosis made at the second visit.
Right carotid bruit heard at the first visit in a man with no symptoms of stroke or transient ischemic attack; carotid duplex ultrasound and vascular neurology consultation requestedresolvedconfirmed R09.89S — Synthetic examination finding; superseded by the duplex result at the second visit.
Asymptomatic atherosclerotic stenosis of the right internal carotid artery, 50 to 69 percent by duplex ultrasound, with less than 50 percent plaque on the left; no stroke or transient ischemic attack; managed with best medical therapy (blood pressure control, a statin and low-dose aspirin) and yearly duplex surveillanceactiveconfirmed I65.21S — Synthetic modern diagnosis made at the vascular neurology consultation; not a claim about his real arteries.
Recent release from about six years of incarceration: re-entering community life on parole at 65, establishing primary care with no medical records yet received, a rented room, no earned income, and a public reputation he feels as a burdenactiveconfirmed Z65.2S — Synthetic modern social problem anchored to his documented imprisonment and parole.
Acute gout of the right first metatarsophalangeal joint, a first flare seven weeks after starting hydrochlorothiazide, diagnosed clinically (sudden overnight onset, redness, swelling and exquisite tenderness of the big toe, no fever); treated with low-dose colchicine; resolvedresolvedconfirmed M10.271S — Synthetic adverse drug effect; not a historical claim.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-07-07Sodium [Moles/volume] in Serum or Plasma140mmol/L136-145 mmol/LNormalS
2026-07-07Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-07-07Creatinine [Mass/volume] in Serum or Plasma0.98mg/dL0.74-1.35 mg/dLNormalS
2026-07-07Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
2026-07-07Hemoglobin A1c/Hemoglobin.total in Blood5.5%<=5.6%NormalS
2026-07-07Hemoglobin [Mass/volume] in Blood14.1g/dL13.2-17.1 g/dLNormalS
2026-07-07Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L7-52 U/LNormalS
2026-07-07Thyrotropin [Units/volume] in Serum or Plasma2.1m[IU]/L0.45-4.5 mIU/LNormalS
2026-07-07Albumin/Creatinine [Mass Ratio] in Urine18mg/gBelow 30NormalS
2026-07-07Cholesterol [Mass/volume] in Serum or Plasma228mg/dL<=199 mg/dLHighS
2026-07-07Cholesterol in HDL [Mass/volume] in Serum or Plasma46mg/dL>=40 mg/dLNormalS
2026-07-07Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation148mg/dLBelow 100HighS
2026-07-07Triglyceride [Mass/volume] in Serum or Plasma170mg/dL<=149 mg/dLHighS
2026-07-07Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay0.08{s_co_ratio}Below 1.00 is nonreactiveNormalS
2026-07-07Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] corrected for background in Blood0.02[IU]/mLBelow 0.35 is negativeNormalS
2026-07-07Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M86mL/min/{1.73_m2}60 or moreNormalS
2026-07-07Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S
2026-08-18Sodium [Moles/volume] in Serum or Plasma136mmol/L136-145 mmol/LNormalS
2026-08-18Potassium [Moles/volume] in Serum or Plasma3.6mmol/L3.5-5.1 mmol/LNormalS
2026-08-18Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.74-1.35 mg/dLNormalS
2026-08-18Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M82mL/min/{1.73_m2}60 or moreNormalS
2026-09-29Urate [Mass/volume] in Serum or Plasma8.4mg/dL3.5-7.2 mg/dLHighS
2026-09-29Sodium [Moles/volume] in Serum or Plasma137mmol/L136-145 mmol/LNormalS
2026-09-29Potassium [Moles/volume] in Serum or Plasma3.7mmol/L3.5-5.1 mmol/LNormalS
2026-09-29Creatinine [Mass/volume] in Serum or Plasma1.04mg/dL0.74-1.35 mg/dLNormalS
2026-09-29Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M80mL/min/{1.73_m2}60 or moreNormalS
2026-09-29Cholesterol [Mass/volume] in Serum or Plasma142mg/dL<=199 mg/dLNormalS
2026-09-29Cholesterol in HDL [Mass/volume] in Serum or Plasma48mg/dL>=40 mg/dLNormalS
2026-09-29Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation68mg/dLBelow 100NormalS
2026-09-29Triglyceride [Mass/volume] in Serum or Plasma130mg/dL<=149 mg/dLNormalS
2026-09-29Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma26U/L7-52 U/LNormalS
2026-10-27Sodium [Moles/volume] in Serum or Plasma139mmol/L136-145 mmol/LNormalS
2026-10-27Potassium [Moles/volume] in Serum or Plasma4.5mmol/L3.5-5.1 mmol/LNormalS
2026-10-27Creatinine [Mass/volume] in Serum or Plasma1.06mg/dL0.74-1.35 mg/dLNormalS
2026-10-27Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M78mL/min/{1.73_m2}60 or moreNormalS
2026-10-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-08-04Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-07-07Body height175cmS
2026-07-07Body weight76kgS
2026-07-07Body mass index (BMI) [Ratio]24.8kg/m2S
2026-07-07Systolic blood pressure166mm[Hg]S
2026-07-07Diastolic blood pressure94mm[Hg]S
2026-07-07Heart rate74/minS
2026-07-07Respiratory rate14/minS
2026-07-07Body temperature36.6CelS
2026-07-07Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-07-21Body height175cmS
2026-07-21Body weight75.8kgS
2026-07-21Body mass index (BMI) [Ratio]24.8kg/m2S
2026-07-21Systolic blood pressure158mm[Hg]S
2026-07-21Diastolic blood pressure92mm[Hg]S
2026-07-21Heart rate72/minS
2026-07-21Respiratory rate14/minS
2026-07-21Body temperature36.5CelS
2026-07-21Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-08-18Body height175cmS
2026-08-18Body weight75.4kgS
2026-08-18Body mass index (BMI) [Ratio]24.6kg/m2S
2026-08-18Systolic blood pressure138mm[Hg]S
2026-08-18Diastolic blood pressure84mm[Hg]S
2026-08-18Heart rate70/minS
2026-08-18Respiratory rate14/minS
2026-08-18Body temperature36.6CelS
2026-08-18Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-09-29Body height175cmS
2026-09-29Body weight75kgS
2026-09-29Body mass index (BMI) [Ratio]24.5kg/m2S
2026-09-29Systolic blood pressure134mm[Hg]S
2026-09-29Diastolic blood pressure80mm[Hg]S
2026-09-29Heart rate68/minS
2026-09-29Respiratory rate14/minS
2026-09-29Body temperature36.5CelS
2026-09-29Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-10-27Body height175cmS
2026-10-27Body weight74.8kgS
2026-10-27Body mass index (BMI) [Ratio]24.4kg/m2S
2026-10-27Systolic blood pressure126mm[Hg]S
2026-10-27Diastolic blood pressure76mm[Hg]S
2026-10-27Heart rate66/minS
2026-10-27Respiratory rate14/minS
2026-10-27Body temperature36.6CelS
2026-10-27Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-08-04Body height175cmS
2026-08-04Body weight75.6kgS
2026-08-04Body mass index (BMI) [Ratio]24.7kg/m2S
2026-08-04Systolic blood pressure144mm[Hg]S
2026-08-04Diastolic blood pressure86mm[Hg]S
2026-08-04Heart rate70/minS
2026-08-04Respiratory rate14/minS
2026-08-04Body temperature36.6CelS
2026-08-04Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-09-08Body height175cmS
2026-09-08Body weight75.2kgS
2026-09-08Body mass index (BMI) [Ratio]24.6kg/m2S
2026-09-08Systolic blood pressure142mm[Hg]S
2026-09-08Diastolic blood pressure86mm[Hg]S
2026-09-08Heart rate78/minS
2026-09-08Respiratory rate14/minS
2026-09-08Body temperature37.2CelS
2026-09-08Oxygen saturation in Arterial blood by Pulse oximetry97%S

Encounters

DatePurposeStatusProvenance
2026-07-07New patient visit to establish care after release from prison: history, medication reconciliation, blood pressure, a right carotid bruit, re-entry screening for hepatitis C, tuberculosis and HIV, mood and social needs, and a vascular neurology referralfinishedS
2026-07-21Two-week follow-up: home blood pressure readings, carotid duplex ultrasound and vascular neurology consultation, starting treatmentfinishedS
2026-08-18Six-week review: blood pressure, electrolytes and kidney function on hydrochlorothiazide and amlodipine; statin and aspirin tolerancefinishedS
2026-09-29Twelve-week review: blood pressure and lipids after a gout flare on hydrochlorothiazide; switch to losartanfinishedS
2026-10-27Sixteen-week review: blood pressure, potassium and kidney function on losartan, mood, social needs and stroke preventionfinishedS
2026-08-04Initial preventive physical examination (Welcome to Medicare)finishedS
2026-09-08Same-day sick visit for a painful, swollen right big toefinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Vascular neurology consultation in two weeks, with carotid duplex ultrasound before it, for a right carotid bruit in a man with high blood pressure: degree of stenosis, medical therapy or revascularization, and surveillancecompletedGL-AHA-STROKE-2024, GL-SVS-CAROTID-2021S
Home blood pressure monitoring twice daily for seven days with a validated upper-arm cuff, to confirm or exclude hypertension before treatment; lower salt, the DASH eating pattern, and daily walkingcompletedGL-AHA-HTN-2025, GL-CMID-2026S
Baseline tests: basic metabolic panel, HbA1c, lipid panel, urine albumin-to-creatinine ratio, TSH, hemoglobin and ALT, and a resting ECG; re-entry screening with a hepatitis C antibody, an interferon-gamma release assay for latent tuberculosis, an HIV test and a hepatitis B panel; PHQ-9completedGL-AHA-HTN-2025, GL-CMID-2026, GL-USPSTF-HCV-2020, GL-CDC-HCV-2020, GL-USPSTF-LTBI-2023, GL-CDC-TB-CORR-2006, GL-USPSTF-DEP-2023S
Re-entry support: a release-of-information request for his prison medical records, a social work referral for housing, Social Security and Medicare enrollment, a low-cost pharmacy plan, and a conversation about shame and reputation, with follow-up of mood at each visitcompletedGL-USPSTF-DEP-2023S
Two first-line drugs for stage 2 hypertension, hydrochlorothiazide 25 mg and amlodipine 5 mg daily, aiming for below 130/80 mmHg, with sodium, potassium and creatinine in about four weekscompletedGL-AHA-HTN-2025, GL-CMID-2026S
Best medical therapy for asymptomatic right carotid stenosis of 50 to 69 percent: atorvastatin 40 mg and aspirin 81 mg daily, a lipid panel and ALT in 4 to 12 weeks, blood pressure control, stroke warning signs and calling 911, and a repeat duplex in twelve monthscompletedGL-AHA-STROKE-2024, GL-SVS-CAROTID-2021, GL-ESVS-CAROTID-2023, GL-ACC-CHOL-2018, GL-CMID-2026S
Switch hydrochlorothiazide to losartan 50 mg daily after a drug-induced gout flare, with potassium and creatinine one to two weeks after starting; no urate-lowering drug after a single flarecompletedGL-ACR-GOUT-2020, GL-AHA-HTN-2025S

Goals

GoalTargetStatusOutcomeProvenance
Office and home blood pressure below 130/80 mmHg by four months2026-10-27completedOffice 126/76 on amlodipine and losartanS
LDL cholesterol lowered by at least half on a statin2026-09-29completedLDL 68 mg/dL, from 148 mg/dL, on atorvastatin 40 mgS
Knows the warning signs of stroke and to call 911 at once2026-07-21completedTaught and repeated back the BE FAST signs at the consultation visitS
A stable room, Social Security and Medicare in place, and a health insurance card in hand2026-09-29completedSix-month lease on his room; retirement benefits and Medicare approvedS

Functional Status

Mental Status